ClinicalTrialsFinder

Sodium-glucose Co-transporter-2 Inhibitors Clinical Trials in Chengdu, Sichuan

1 recruitingChengdu, Sichuan, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Peritoneal Dialysis ComplicationSodium-glucose Co-transporter-2 InhibitorsRenal Function Aggravated
Sichuan Academy of Medical Sciences70 enrolled1 locationNCT06398977